Campbell & CO Investment Adviser LLC Kodiak Sciences Inc. Call Options Transaction History
Campbell & CO Investment Adviser LLC
- $1.26 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KOD
# of Institutions
108Shares Held
40.2MCall Options Held
73.7KPut Options Held
0-
Baker Bros. Advisors LP New York, NY17.3MShares$327 Million0.65% of portfolio
-
Black Rock Inc. New York, NY3.85MShares$72.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$36.8 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA1.34MShares$25.2 Million0.04% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.27MShares$23.9 Million0.53% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $982M
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...